Manufacturing Infrastructure / R&D capabilities

Aditri’s collaborative manufacturing facilities are state-of-the-art, multipurpose facilities that comply with cGMP standards and meet the requirements of US and EU Drug regulatory authorities.

Finished Formulator - M/S. Steril Gene Life Sciences Pvt Ltd INDIA, has an annual manufacturing capacity of 3 billion Tablets and 1 Billion capsules. The facility is approved by WHO Geneva, USA FDA, UK MHRA EU GMP ANVISA (Brazil) DGMED, Health Canada, TGA Australia, MTMDA (Tanzania), MCAZ (Zimbabwe)

A.P.I. Manufacturing Facility – VINTA LABS LTD based out of INDIA has an annual manufacturing capacity of 150KL. Manufacturing capabilities include Research & Development.

BA/BE Partners are based in INDIA and USFDA approved labs.